LIVE WEBINAR

Preconception GLP RA-1

     

OVERVIEW

ADA Member Exclusive WebinarThis interactive session will explore familiar sources of funding for diabetes education programs, highlight the unique strengths of DSMES initiatives that resonate with grant funders, and provide a practical approach to designing successful grant proposals, programs, and partnerships. By the end of the webinar, attendees will understand the indicated use of GLP-1 receptor agonists (GLP-1 RAs) and current recommendations in the preconception period, recognize the risks and benefits of preconception use of GLP-1 RAs, and review the evidence regarding GLP-1 RA use during and after pregnancy. The session will conclude with actionable insights and a live Q&A to help you take the following steps in securing support for your diabetes education efforts.

LEARNING OBJECTIVES

  • Attendees will know indicated use of GLP-1 RAs and current recommendations in the preconception period
  • Attendees will know the risks and benefits of preconception use of GLP-1RAs
  • Attendees will know the evidence regarding use of GLP RA-1 during and after pregnancy

DATE AND TIME

Jan 23, 2026 1:00 PM - 2:00 PM ET

SPEAKERS


Jacqueline Maya, MD
Pediatric Endocrinology at Mass General Brigham for Children  

MODERATOR

Christopher Nau, MD
Director of Diabetes in Pregnancy Program at University Hospitals

Laura Dickens
Assistant Professor of Medicine
Co-Director, Diabetes in Pregnancy Program at University of Chicago Medicine

Android App Download IOS App Download Powered By